Avibela™ - 52mg Levonorgestrel IUD
This webinar offered a general vision of the 52mg Levonorgestrel IUD called Avibela™, which has been launched to the market by Medicines360, a non profit pharmaceutical company dedicated to women’s products and based in San Francisco, USA. The vision and mission of Medicines360 was presented and its role in the global Family Planning community. Medicines360 also presented the ways it works with partners and allies. The webinar explained the current status of Avibela™ introduction in low and middle income countries as well as its pharmaceutical features, its indications and duration.